ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted February 25, 2011

Weight Supplement Found by FDA to Contain Prescription Drug

The U.S. FDA posted an announcement (dated February 9, 2011) by Svelte 30 Nutritional Consultants indicating that a sample of Svelte 30 orange & gray capsule was collected and tested by FDA in January 2011. The capsules tested positive for Sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss. The FDA has not approved Svelte 30 orange & gray capsules as drugs; therefore the safety and effectiveness of this product is unknown.

FDA advises that these products may pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

Svelte 30 orange & gray capsules are marketed as a Natural Herb for Weight Loss. Svelte 30 Herb Supplement is packaged in plastic bottles containing 30 capsules per bottle and bears UPC #’s from 04-3000 to 04-5999. Were MFD: 10/22/2010 with EXP: 10/21/2012. This lot would have been available for sale on January 03, 2011.

The lots from 04-3000 to 04-5999 is the only one subject to recall and it was not distributed through www.svelte.com1 The product was sold directly to individual customers in its Kissimmee, Florida sales office. The company discontinued total distribution.

No illnesses or injuries have been reported to the company to date in connection with this product. This recall is being conducted with the knowledge of the FDA.

Consumers should not consume Svelte 30 orange & gray capsules Herb Supplement and should return it immediately to the place of purchase for a refund.

For more information, use the link below.